Literature DB >> 19904197

HLA-B molecules target more conserved regions of the HIV-1 proteome.

Ana I Fontaine Costa1, Xiangyu Rao, Emmanuelle Lechenadec, Debbie van Baarle, Can Keşmir.   

Abstract

BACKGROUND: HLA-B alleles of HIV-infected individuals have been shown to have a major impact on their rate of progression toward AIDS, and the T-cell responses they restrict are immunodominant.
OBJECTIVE: We sought to identify whether the association of HLA-B alleles with rate of progression toward AIDS is due to targeting of more restricted and thus more conserved regions of the HIV-1 proteome.
METHODS: Each residue of the HIV-1 consensus subtype B sequence was coded according to the presence/absence of an epitope, using the compiled epitope data available in the HIV-LANL immunology database. The Shannon entropy for each HXB2 position was calculated using pre-aligned HIV-1 clade B sequences as a measure of its degree of conservation. We then compared the entropy of empty versus epitope-containing positions and HLA-B-restricted versus HLA-A-restricted positions.
RESULTS: Positions containing CD8 epitopes were significantly more conserved than corresponding empty positions. Moreover, residues targeted by HLA-B alleles in the HIV-1 proteome were significantly more conserved than the ones targeted by HLA-A alleles. Analysing a recent dataset, we found that B epitope regions contain significantly more escape mutations and reversions, which might be the reason why we find them to be more conserved.
CONCLUSION: Our results suggest that epitopes in HIV-1 targeted by HLA-B alleles lie in more constrained regions of its proteins, in which mutations might have a higher fitness cost and tend to revert. Consequently, HLA-B-restricted cytotoxic T-lymphocyte (CTL) responses may persist longer. This may be one of the factors contributing to the immunodominance and impact of HLA-B-restricted CTL responses on disease progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19904197     DOI: 10.1097/QAD.0b013e328334442e

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Authors:  Christoph T Berger; Nicole Frahm; David A Price; Beatriz Mothe; Musie Ghebremichael; Kari L Hartman; Leah M Henry; Jason M Brenchley; Laura E Ruff; Vanessa Venturi; Florencia Pereyra; John Sidney; Alessandro Sette; Daniel C Douek; Bruce D Walker; Daniel E Kaufmann; Christian Brander
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response.

Authors:  Raghavan Sampathkumar; Elnaz Shadabi; Ma Luo
Journal:  Adv Virol       Date:  2012-05-16

3.  Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.

Authors:  Pratima Kunwar; Natalie Hawkins; Warren L Dinges; Yi Liu; Erin E Gabriel; David A Swan; Claire E Stevens; Janine Maenza; Ann C Collier; James I Mullins; Tomer Hertz; Xuesong Yu; Helen Horton
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

4.  HIV-1 envelope accessible surface and polarity: clade, blood, and brain.

Authors:  Gopichandran Sowmya; Gunasagaran Shamini; Sathyanarayanan Anita; Meena Sakharkar; Venkat Mathura; Hector Rodriguez; Andrew J Levine; Elyse Singer; Deborah Commins; Charurut Somboonwit; John T Sinnott; Harcharan S Sidhu; Ganapathy Rajaseger; Peter Natesan Pushparaj; Pandajarasamme Kangueane; Paul Shapshak
Journal:  Bioinformation       Date:  2011-03-22

5.  Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.

Authors:  Guido Ferrari; Bette Korber; Nilu Goonetilleke; Michael K P Liu; Emma L Turnbull; Jesus F Salazar-Gonzalez; Natalie Hawkins; Steve Self; Sydeaka Watson; Michael R Betts; Cynthia Gay; Kara McGhee; Pierre Pellegrino; Ian Williams; Georgia D Tomaras; Barton F Haynes; Clive M Gray; Persephone Borrow; Mario Roederer; Andrew J McMichael; Kent J Weinhold
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

6.  Estimating the fitness cost of escape from HLA presentation in HIV-1 protease and reverse transcriptase.

Authors:  Rafal Mostowy; Roger D Kouyos; Ilka Hoof; Trevor Hinkley; Mojgan Haddad; Jeannette M Whitcomb; Christos J Petropoulos; Can Keşmir; Sebastian Bonhoeffer
Journal:  PLoS Comput Biol       Date:  2012-05-24       Impact factor: 4.475

7.  Immune activation promotes evolutionary conservation of T-cell epitopes in HIV-1.

Authors:  Rafael Sanjuán; Miguel R Nebot; Joan B Peris; José Alcamí
Journal:  PLoS Biol       Date:  2013-04-02       Impact factor: 8.029

Review 8.  Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine.

Authors:  Sajib Chakraborty; Taibur Rahman; Rajib Chakravorty
Journal:  Adv Virol       Date:  2014-03-18

9.  HLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance.

Authors:  Xiangyu Rao; Ilka Hoof; Debbie van Baarle; Can Keşmir; Johannes Textor
Journal:  Front Immunol       Date:  2015-10-29       Impact factor: 7.561

10.  Editorial: Role of HLA and KIR in Viral Infections.

Authors:  Jelle de Wit; José A M Borghans; Can Kesmir; Debbie van Baarle
Journal:  Front Immunol       Date:  2016-07-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.